Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 193

1.

Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study.

Zanichelli A, Bova M, Coerezza A, Petraroli A, Triggiani M, Cicardi M.

Allergy. 2012 Aug;67(8):1074-7. doi: 10.1111/j.1398-9995.2012.02853.x. Epub 2012 Jun 12.

2.

Randomized placebo-controlled trial of the bradykinin B₂ receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial.

Lumry WR, Li HH, Levy RJ, Potter PC, Farkas H, Moldovan D, Riedl M, Li H, Craig T, Bloom BJ, Reshef A.

Ann Allergy Asthma Immunol. 2011 Dec;107(6):529-37. doi: 10.1016/j.anai.2011.08.015. Epub 2011 Oct 5.

PMID:
22123383
3.

Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (Icatibant).

Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W.

J Allergy Clin Immunol. 2007 Jun;119(6):1497-503. Epub 2007 Apr 5.

PMID:
17418383
4.

Repeat treatment with icatibant for multiple hereditary angioedema attacks: FAST-2 open-label study.

Baş M, Greve J, Hoffmann TK, Reshef A, Aberer W, Maurer M, Kivity S, Farkas H, Floccard B, Arcoleo F, Martin L, Sitkauskiene B, Bouillet L, Schmid-Grendelmeier P, Li H, Zanichelli A.

Allergy. 2013 Nov;68(11):1452-9. doi: 10.1111/all.12244. Epub 2013 Sep 21.

5.

Hereditary angioedema attacks resolve faster and are shorter after early icatibant treatment.

Maurer M, Aberer W, Bouillet L, Caballero T, Fabien V, Kanny G, Kaplan A, Longhurst H, Zanichelli A; I O S Investigators.

PLoS One. 2013;8(2):e53773. doi: 10.1371/journal.pone.0053773. Epub 2013 Feb 4.

6.

Icatibant. Attacks of hereditary angioedema: continue to use C1 esterase inhibitor.

[No authors listed]

Prescrire Int. 2010 Nov;19(110):245-7. Review.

PMID:
21284353
7.

Successful long-term treatment with the bradykinin B2 receptor antagonist icatibant in a patient with hereditary angioedema.

Greve J, Hoffmann TK, Schuler P, Lang S, Chaker A, Bas M.

Int J Dermatol. 2011 Oct;50(10):1294-5. doi: 10.1111/j.1365-4632.2011.05051.x.

PMID:
21950301
8.

Repeat treatment of acute hereditary angioedema attacks with open-label icatibant in the FAST-1 trial.

Malbrán A, Riedl M, Ritchie B, Smith WB, Yang W, Banerji A, Hébert J, Gleich GJ, Hurewitz D, Jacobson KW, Bernstein JA, Khan DA, Kirkpatrick CH, Resnick D, Li H, Fernández Romero DS, Lumry W.

Clin Exp Immunol. 2014 Aug;177(2):544-53. doi: 10.1111/cei.12358.

9.

Icatibant for the treatment of hereditary angioedema.

Cole SW, Lundquist LM.

Ann Pharmacother. 2013 Jan;47(1):49-55. doi: 10.1345/aph.1R423. Epub 2012 Dec 18. Review.

PMID:
23249729
10.

Switch to icatibant in a patient affected by hereditary angioedema with high disease activity: a case report.

Firinu D, Barca MP, Serusi L, Lorrai MM, Peralta MM, Manconi PE, Del Giacco SR.

Int J Immunopathol Pharmacol. 2012 Jan-Mar;25(1):269-73.

PMID:
22507340
12.

Rapid resolution of erythema marginatum after icatibant in acquired angioedema.

Bygum A, Broesby-Olsen S.

Acta Derm Venereol. 2011 Mar;91(2):185-6. doi: 10.2340/00015555-1055. No abstract available.

13.

Icatibant for hereditary angioedema.

Gras J.

Drugs Today (Barc). 2009 Dec;45(12):855-64. doi: 1396674/dot.2009.45.12.1424267. Review.

PMID:
20135020
14.

Treatment of hereditary angioedema with icatibant: efficacy in clinical trials versus effectiveness in the real-world setting.

Maurer M, Longhurst HJ, Fabien V, Li HH, Lumry WR.

Allergy Asthma Proc. 2014 Sep-Oct;35(5):377-81. doi: 10.2500/aap.2014.35.3780. Epub 2014 Aug 6.

PMID:
25198193
15.

Icatibant, an inhibitor of bradykinin receptor 2, for hereditary angioedema attacks: prospective experimental single-cohort study.

Campos RA, Valle SO, França AT, Cordeiro E, Serpa FS, Mello YF, Malheiros T, Toledo E, Mansour E, Fusaro G, Grumach AS.

Sao Paulo Med J. 2014;132(5):261-5. Epub 2014 Jul 22.

16.

Bradykinin receptor 2 antagonist (icatibant) for hereditary angioedema type III attacks.

Bouillet L, Boccon-Gibod I, Ponard D, Drouet C, Cesbron JY, Dumestre-Perard C, Monnier N, Lunardi J, Massot C, Gompel A.

Ann Allergy Asthma Immunol. 2009 Nov;103(5):448. doi: 10.1016/S1081-1206(10)60369-9. No abstract available.

PMID:
19927548
17.

Icatibant.

Deeks ED.

Drugs. 2010;70(1):73-81. doi: 10.2165/11204500-000000000-00000.

PMID:
20030426
18.

Therapeutic efficacy of icatibant in angioedema induced by angiotensin-converting enzyme inhibitors: a case series.

Bas M, Greve J, Stelter K, Bier H, Stark T, Hoffmann TK, Kojda G.

Ann Emerg Med. 2010 Sep;56(3):278-82. doi: 10.1016/j.annemergmed.2010.03.032. Epub 2010 May 5.

PMID:
20447725
19.

[Angiotensin-converting enzyme inhibitor induced angioedema : new therapy options].

Bas M, Kojda G, Stelter K.

Anaesthesist. 2011 Dec;60(12):1141-5. doi: 10.1007/s00101-010-1798-3. Epub 2010 Oct 6. German.

PMID:
20922352
20.

Hereditary angioedema therapies in the United States: movement toward an international treatment consensus.

Riedl M.

Clin Ther. 2012 Mar;34(3):623-30. doi: 10.1016/j.clinthera.2012.02.003. Epub 2012 Mar 2.

PMID:
22386830
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk